Dr. Christina S. Wu
Claim this profileEmory University Hospital/Winship Cancer Institute
Studies Colorectal Cancer
Studies Adenocarcinoma
10 reported clinical trials
24 drugs studied
Area of expertise
1Colorectal Cancer
Stage IV
BRAF negative
HRD positive
2Adenocarcinoma
Stage IV
HRD positive
BRCA2 positive
Affiliated Hospitals
Clinical Trials Christina S. Wu is currently running
Ablative Therapy + Systemic Therapy
for Colorectal Cancer
This phase III trial compares total ablative therapy and usual systemic therapy to usual systemic therapy alone in treating patients with colorectal cancer that has spread to up to 4 body sites (limited metastatic). The usual approach for patients who are not participating in a study is treatment with intravenous (IV) (through a vein) and/or oral medications (systemic therapy) to help stop the cancer sites from getting larger and the spread of the cancer to additional body sites. Ablative means that the intention of the local treatment is to eliminate the cancer at that metastatic site. The ablative local therapy will consist of very focused, intensive radiotherapy called stereotactic ablative radiotherapy (SABR) with or without surgical resection and/or microwave ablation, which is a procedure where a needle is temporarily inserted in the tumor and heat is used to destroy the cancer cells. SABR, surgical resection, and microwave ablation have been tested for safety, but it is not scientifically proven that the addition of these treatments are beneficial for your stage of cancer. The addition of ablative local therapy to all known metastatic sites to the usual approach of systemic therapy could shrink or remove the tumor(s) or prevent the tumor(s) from returning.
Recruiting2 awards Phase 3
Irinotecan + FOLFOX Chemotherapy
for Rectal Cancer
This trial is testing different treatments in patients with advanced rectal cancer to see which one is more effective at shrinking the tumor or stopping its growth, potentially avoiding surgery.
Recruiting1 award Phase 2
More about Christina S. Wu
Clinical Trial Related4 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Christina S. Wu has experience with
- Fluorouracil
- Leucovorin Calcium
- Fruquintinib
- Bevacizumab
- Irinotecan
- Liposomal Irinotecan
Breakdown of trials Christina S. Wu has run
Colorectal Cancer
Adenocarcinoma
Colon Cancer
Rectal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Christina S. Wu specialize in?
Christina S. Wu focuses on Colorectal Cancer and Adenocarcinoma. In particular, much of their work with Colorectal Cancer has involved Stage IV patients, or patients who are BRAF negative.
Is Christina S. Wu currently recruiting for clinical trials?
Yes, Christina S. Wu is currently recruiting for 2 clinical trials in Atlanta Georgia. If you're interested in participating, you should apply.
Are there any treatments that Christina S. Wu has studied deeply?
Yes, Christina S. Wu has studied treatments such as Fluorouracil, Leucovorin Calcium, Fruquintinib.
What is the best way to schedule an appointment with Christina S. Wu?
Apply for one of the trials that Christina S. Wu is conducting.
What is the office address of Christina S. Wu?
The office of Christina S. Wu is located at: Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia 30322 United States. This is the address for their practice at the Emory University Hospital/Winship Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.